Detection of Sporadic Outbreaks of Rift Valley Fever in Uganda through the National Viral Hemorrhagic Fever Surveillance System, 2017-2020.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
03 05 2023
Historique:
received: 20 06 2022
accepted: 22 11 2022
medline: 5 5 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: epublish

Résumé

Rift Valley fever (RVF) is a zoonotic disease of public health and economic importance. Uganda has reported sporadic outbreaks of RVF in both humans and animals across the country, especially in the southwestern part of the "cattle corridor" through an established viral hemorrhagic fever surveillance system. We report 52 human cases of laboratory-confirmed RVF from 2017 to 2020. The case fatality rate was 42%. Among those infected, 92% were males and 90% were adults (≥ 18 years). Clinical symptoms were characterized by fever (69%), unexplained bleeding (69%), headache (51%), abdominal pain (49%), and nausea and vomiting (46%). Most of the cases (95%) originated from central and western districts that are part of the cattle corridor of Uganda, where the main risk factor was direct contact with livestock (P = 0.009). Other predictors of RVF positivity were determined to be male gender (P = 0.001) and being a butcher (P = 0.04). Next-generation sequencing identified the predominant Ugandan clade as Kenya-2, observed previously across East Africa. There is need for further investigation and research into the effect and spread of this neglected tropical disease in Uganda and the rest of Africa. Control measures such as promoting vaccination and limiting animal-human transmission could be explored to reduce the impact of RVF in Uganda and globally.

Identifiants

pubmed: 36913925
doi: 10.4269/ajtmh.22-0410
pii: tpmd220410
pmc: PMC10160879
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

995-1002

Références

Emerg Infect Dis. 2002 Dec;8(12):1415-20
pubmed: 12498657
PLoS Negl Trop Dis. 2018 May 3;12(5):e0006412
pubmed: 29723189
Ann Trop Med Parasitol. 1972 Sep;66(3):343-55
pubmed: 4404504
Am J Trop Med Hyg. 2019 Mar;100(3):659-671
pubmed: 30675833
J Clin Microbiol. 2007 Nov;45(11):3506-13
pubmed: 17804663
Lancet Infect Dis. 2018 Apr;18(4):373-375
pubmed: 29582758
Arch Virol. 2019 Mar;164(3):927-941
pubmed: 30663021
Med Vet Entomol. 2005 Jun;19(2):119-26
pubmed: 15958020
Am J Trop Med Hyg. 2015 Apr;92(4):722-9
pubmed: 25732680
PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005226
pubmed: 28068340
Emerg Microbes Infect. 2017 Jan 18;6(1):e4
pubmed: 28096531
Asian Pac J Trop Biomed. 2017 May;7(5):483-491
pubmed: 32289025
PLoS One. 2013 Nov 13;8(11):e78609
pubmed: 24236026
PLoS Negl Trop Dis. 2015 Dec 22;9(12):e0004314
pubmed: 26694834
PLoS Negl Trop Dis. 2018 Mar 5;12(3):e0006175
pubmed: 29505579
Infect Ecol Epidemiol. 2015 Jul 31;5:28024
pubmed: 26234531
J Infect Dis. 2015 Oct 1;212 Suppl 2:S119-28
pubmed: 26209681
J Virol Methods. 2007 Dec;146(1-2):119-24
pubmed: 17645952
Am J Trop Med Hyg. 2010 Aug;83(2 Suppl):5-13
pubmed: 20682900
Emerg Infect Dis. 2011 Dec;17(12):2270-6
pubmed: 22172568
Int J Infect Dis. 2010 Feb;14(2):e179-80
pubmed: 19570703
PLoS Negl Trop Dis. 2015 Feb 27;9(2):e0003536
pubmed: 25723502
PLoS Negl Trop Dis. 2022 Feb 22;16(2):e0010205
pubmed: 35192613
PLoS Negl Trop Dis. 2020 Feb 21;14(2):e0007979
pubmed: 32084127
MMWR Morb Mortal Wkly Rep. 2007 Feb 2;56(4):73-6
pubmed: 17268404
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Vector Borne Zoonotic Dis. 2009 Dec;9(6):579-82
pubmed: 19125662
J Infect Dis. 2016 Oct 15;214(suppl 3):S122-S136
pubmed: 27587635

Auteurs

Luke Nyakarahuka (L)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Department of Biosecurity, Ecosystems and Veterinary Public Health, Makerere University, Kampala, Uganda.

Shannon Whitmer (S)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

John Klena (J)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Stephen Balinandi (S)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Emir Talundzic (E)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Alex Tumusiime (A)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Jackson Kyondo (J)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Sophia Mulei (S)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Ketan Patel (K)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Jimmy Baluku (J)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Gloria Akurut (G)

Uganda Wildlife Authority, Kampala, Uganda.

Diana Namanya (D)

Uganda Wildlife Authority, Kampala, Uganda.

Kilama Kamugisha (K)

Uganda Wildlife Authority, Kampala, Uganda.

Caitlin Cossaboom (C)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Amy Whitesell (A)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Carson Telford (C)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

James Graziano (J)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Joel Montgomery (J)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Stuart Nichol (S)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Julius Lutwama (J)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Trevor Shoemaker (T)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH